KAIRAX SUB Q

KAIRAX SUB-Q™ with Lidocaine is a premium, CE-certified hyaluronic acid dermal filler designed for deep facial volumization, contour enhancement, and correction of significant volume loss. Formulated with highly cross-linked hyaluronic acid, this monophasic filler provides excellent lifting capacity, structural support, and long-lasting aesthetic results. The addition of lidocaine helps improve patient comfort during treatment.

KAIRAX SUB-Q™ is particularly suitable for restoring facial contours and creating definition in areas requiring substantial augmentation, including the cheeks, chin, jawline, and nose.

Composition

Active Ingredients

• Cross-linked Hyaluronic Acid (HA): 24 mg/mL

• Lidocaine Hydrochloride: 0.3%

Product Characteristics

• Monophasic gel technology

• High cohesivity and viscosity

• Excellent tissue integration

• Smooth and uniform gel consistency

Indications

KAIRAX SUB-Q™ is indicated for:

• Correction of deep wrinkles and severe facial folds

• Treatment of pronounced nasolabial folds

• Improvement of marionette lines

• Restoration of age-related facial volume loss

• Cheek augmentation and contour enhancement

• Chin projection and reshaping

• Jawline definition

• Non-surgical nasal contouring and profile refinement

• Facial sculpting and structural support

Areas of Treatment

Suitable treatment areas include:

• Cheeks

• Chin

• Jawline

• Nose

• Nasolabial folds

• Marionette lines

• Facial volume-deficient regions

Method of Administration

Injection Depth

• Deep dermis

• Subcutaneous tissue

• Supraperiosteal layer

Recommended Techniques

• Linear threading

• Retrograde injection

• Bolus injection

• Layered volumization techniques

The product should only be administered by trained and qualified medical professionals experienced in dermal filler procedures.

Benefits

• Immediate volumizing effect

• High lifting capacity

• Long-lasting aesthetic outcomes

• Smooth and natural-looking results

• Excellent facial contour definition

• Enhanced patient comfort through lidocaine inclusion

• High resistance to degradation due to advanced cross-linking technology

Expected Results and Duration

Results

• Immediate restoration of facial volume

• Enhanced contour definition

• Improved facial balance and symmetry

• Reduction of deep folds and wrinkles

Longevity

Results typically last between 12 and 18 months, depending on:

• Patient metabolism

• Age and lifestyle factors

• Treatment area

• Injection technique

• Volume injected

Periodic maintenance treatments may help prolong results.

Safety Information and Precautions

Before Treatment

Patients should consult their healthcare provider regarding:

• Blood-thinning medications

• Aspirin and NSAIDs

• Vitamin supplements that may increase bruising risk

After Treatment

For optimal results, patients should:

• Avoid excessive sun exposure and UV radiation

• Avoid saunas, steam rooms, and extreme temperatures

• Refrain from applying pressure to treated areas

• Avoid strenuous physical activity for the first 24–48 hours

Storage Conditions

• Store at temperatures between 2°C and 25°C

• Protect from direct sunlight

• Do not freeze

• Keep in original packaging until use

Shelf Life

• Up to 24 months from the date of manufacture when stored according to recommended conditions.

Packaging

Each package contains:

• 1 × 1.0 mL prefilled syringe of KAIRAX SUB-Q™

• 2 × 25G × ½″ sterile ultra-thin wall needles

• Product instructions for professional use

Technical Specifications

Country of Origin

South Korea